Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy-Reference-Cited by-同舟云学术

Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy

Published:2020-04-22 Issue:17 Volume:63 Page:8977-9002
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Liu Tingting¹^ORCID,Wan Yichao²,Xiao Yuliang¹,Xia Chengcai¹^ORCID,Duan Guiyun¹

Affiliation:

1. Department of Medicinal Chemistry, School of Pharmacy, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian 271016, Shandong, China

2. Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan 411201, Hunan, China

Funder

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00491

Reference209 articles.

1. Combination therapy in combating cancer

2. Overcoming limitations of natural anticancer drugs by combining with artificial agents

3. Multi-Targeting Anticancer Agents: Rational Approaches, Synthetic Routes and Structure Activity Relationship